Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-019-00680-5
Published Online: 2019-08-22
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagahisa, Taichi
Saisho, Yoshifumi http://orcid.org/0000-0002-6071-4393
Text and Data Mining valid from 2019-08-22
Version of Record valid from 2019-08-22
Article History
Received: 6 June 2019
First Online: 22 August 2019